Search

Your search keyword '"Taste Disorders"' showing total 5,286 results

Search Constraints

Start Over You searched for: Descriptor "Taste Disorders" Remove constraint Descriptor: "Taste Disorders"
5,286 results on '"Taste Disorders"'

Search Results

51. Prevalence and trends in persistent symptoms following COVID-19 in Japan: A nationwide cross-sectional survey.

52. Alpha Synuclein Toxicity and Non-Motor Parkinson's.

53. Postacute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study.

54. Zinc supplementation for dysgeusia in patients with unresectable pancreatic cancer.

55. Social impact of brain fog and analysis of risk factors: Long COVID in Japanese population.

56. A Nationwide survey of safety protocols and chemosensory assessments by Japanese clinicians pre- and post-COVID-19 pandemic.

57. Serum zinc, selenium, and vitamin D levels in patients with acne vulgaris: A case–control study.

58. Smell and Taste Alterations in Patients Receiving Curative or Palliative Chemotherapy—The CONKO 021—ChemTox Trial.

59. Comprehensive Analysis of COVID-19 Symptomatology among Healthcare Workers: Insights from a Tertiary Hospital.

60. Neurological Manifestations and Comorbidities in Coronavirus Disease 2019 (COVID-19) Patients: Multicenter Study.

61. Long COVID in Children and Adolescents: Implications for Nursing Management.

62. Predictors of Subjective Olfactory Dysfunction and Sinonasal Quality-of-Life After Endoscopic Transsphenoidal Pituitary Surgery.

63. The most important variables associated with death due to COVID‐19 disease, based on three data mining models Decision Tree, AdaBoost, and Support Vector Machine: A cross‐sectional study.

64. Machine learning algorithms for predicting COVID-19 mortality in Ethiopia.

65. Efficacy and Safety of Habitual Consumption of a Food Supplement Containing Miraculin in Malnourished Cancer Patients: The CLINMIR Pilot Study.

66. Effectiveness of Snoezelen in older adults with neurocognitive and other pathologies: A systematic review of the literature.

67. Long-term effects of SARS-CoV-2 infection in patients with and without chemosensory disorders at disease onset: a psychophysical and magnetic resonance imaging exploratory study.

68. Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping Review.

69. Association of Symptoms and Viral Culture Positivity for SARS‐CoV‐2—Tennessee, April–July 2020.

70. The Impact of COVID-19 on the Guillain–Barré Syndrome Incidence.

71. Taste and Smell Alterations (TSAs) in Cancer Patients.

73. Taste disorders and alopecia in myasthenia gravis

74. Physiological Integration of Taste and Metabolism.

75. Assessment of olfactory and gustatory functions in COVID-19 patients.

76. Oral symptoms potentially associated with mild-to-moderate COVID-19 in tobacco users.

77. Updates in Cancer Cachexia: Clinical Management and Pharmacologic Interventions.

78. Dyschromatopsia and contrast sensitivity changes in COVID-19 patients.

79. Factors associated with impaired psychophysical gustatory function.

80. 口腔湿度检测装置辅助评价鼻咽癌放射治疗腮腺受 损程度的研究.

81. The Effectiveness of Garlic Consumption on Improving Anosmia and Dysgeusia in Patients with COVID-19.

82. Variant-specific Symptoms After COVID-19: A Hospital-based Study in Hiroshima.

83. Taste disorders and alopecia in myasthenia gravis.

84. Druggable site near the upper vestibule determines the high affinity and P2X3 homotrimer selectivity of sivopixant/S‐600918 and its analogue DDTPA.

85. Expression analysis of zinc-metabolizing enzymes in the saliva as a new method of evaluating zinc content in the body: two case reports and a review of the literature.

86. Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trial.

87. The effect of post‐COVID‐19 on gustatory and olfactory function: A preliminary case‐controlled study.

88. Optogenetics in taste research: A decade of enlightenment.

89. Individuals who have been infected with SARS‐CoV‐2 remain with lowered taste and smell sensory‐processing sensitivity: A case study.

90. Efficacy and safety of alpha-pinene capsule in the management of functional dyspepsia and eradication of helicobacter pylori: a randomized clinical trial.

91. Decrease of 7T MR short-term effects with repeated exposure.

92. A rare symptom of foodborne botulism: dysgeusia. Case report and clinical review.

93. Bilateral hypogeusia and food aversion due to lacunar infarct in the right dorsomedial pontine tegmentum.

94. Oral Risk Factors in Patients with Cancer Undergoing Chemotherapy - A Pilot Study.

95. Taste Dysfunction and its Relationship to HbA1C Level and Disease Duration in Type 2 Diabetes Mellitus Patients with Autonomic Neuropathy.

96. Living and Coping with Olfactory and Taste Disorders: A Qualitative Study of People with Long-COVID-19.

97. What is the impact of long-term COVID-19 on workers in healthcare settings? A rapid systematic review of current evidence.

98. Prevalence and Factors Associated with Olfactory Dysfunction in Individuals with COVID-19 in Brazil: A Study of 20,669 Cases from 2020 to 2021.

99. Latest discoveries related to taste and smell disorders in patients with post-COVID-19 and other neuroviruses - a systematic literature review.

100. COVID‐19 infection in patients with history of pediatric heart transplant in Germany, Austria, and Switzerland.

Catalog

Books, media, physical & digital resources